Search research articles
Contact Us
Filters
Showing results (91-100 of 161) with videos related to
Page
of 17
Sort By:
Journal of Gastroenterology
|
October 19, 2018
Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures
Mitsutaka Osawa, Michio Imamura, Yuji Teraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 9, 2020
Impact of viral eradication by direct-acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus-related compensated cirrhosis patients
Yuko Nagaoki, Michio Imamura, Yuji Teraoka, et al.
Journal of Hepatology
|
April 8, 2015
Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A
Sakura Akamatsu, C Nelson Hayes, Hidenori Ochi, et al.
Cancer Medicine
|
March 8, 2024
Clinicopathological and genomic features of superficial esophageal squamous cell carcinomas in nondrinker, nonsmoker females
Motomitsu Fukuhara, Yuji Urabe, Hikaru Nakahara, et al.
Journal of Gastroenterology
|
February 22, 2012
IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients
Mayu Ohnishi, Masataka Tsuge, Tomohiko Kohno, et al.
JCO Clinical Cancer Informatics
|
December 18, 2024
Prediction of Hepatocellular Carcinoma After Hepatitis C Virus Sustained Virologic Response Using a Random Survival Forest Model
Hikaru Nakahara, Atsushi Ono, C Nelson Hayes, et al.
The Journal of General Virology
|
March 12, 2010
HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice
Masataka Tsuge, Nobuhiko Hiraga, Rie Akiyama, et al.
Medicine
|
September 17, 2024
Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma
Ryoichi Miura, Atsushi Ono, Shigeki Yano, et al.
The Journal of General Virology
|
January 14, 2011
IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations
Hidenori Ochi, Toshiro Maekawa, Hiromi Abe, et al.
Plos One
|
March 3, 2017
Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus
Eisuke Miyaki, Nobuhiko Hiraga, Michio Imamura, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 161) with videos related to
Sort By:
Page
of 17
Journal of Gastroenterology
|
October 19, 2018
Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures
Mitsutaka Osawa, Michio Imamura, Yuji Teraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 9, 2020
Impact of viral eradication by direct-acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus-related compensated cirrhosis patients
Yuko Nagaoki, Michio Imamura, Yuji Teraoka, et al.
Journal of Hepatology
|
April 8, 2015
Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A
Sakura Akamatsu, C Nelson Hayes, Hidenori Ochi, et al.
Cancer Medicine
|
March 8, 2024
Clinicopathological and genomic features of superficial esophageal squamous cell carcinomas in nondrinker, nonsmoker females
Motomitsu Fukuhara, Yuji Urabe, Hikaru Nakahara, et al.
Journal of Gastroenterology
|
February 22, 2012
IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients
Mayu Ohnishi, Masataka Tsuge, Tomohiko Kohno, et al.
JCO Clinical Cancer Informatics
|
December 18, 2024
Prediction of Hepatocellular Carcinoma After Hepatitis C Virus Sustained Virologic Response Using a Random Survival Forest Model
Hikaru Nakahara, Atsushi Ono, C Nelson Hayes, et al.
The Journal of General Virology
|
March 12, 2010
HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice
Masataka Tsuge, Nobuhiko Hiraga, Rie Akiyama, et al.
Medicine
|
September 17, 2024
Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma
Ryoichi Miura, Atsushi Ono, Shigeki Yano, et al.
The Journal of General Virology
|
January 14, 2011
IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations
Hidenori Ochi, Toshiro Maekawa, Hiromi Abe, et al.
Plos One
|
March 3, 2017
Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus
Eisuke Miyaki, Nobuhiko Hiraga, Michio Imamura, et al.
Page
of 17